ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for default 무료로 등록하여 실시간 주식 시세, 대화형 차트, 실시간 옵션 플로우 등을 받아보세요.

LYEL Lyell Immunopharma Inc

2.36
-0.04 (-1.67%)
04 5월(5) 2024 - 마감
15분 지연
기업명 주식 심볼 시장 주식 타입
Lyell Immunopharma Inc LYEL 나스닥 보통주
  가격 변동 가격 변동 % 주식 가격 최근 거래 시간
-0.04 -1.67% 2.36 09:00:00
개장가 저가 고가 종가 전일 종가
2.44 2.35 2.66 2.36 2.40
시세 정보 더보기 »

최근 뉴스

일자 시간 출처 제목
06/03/202406:30GLOBELyell Immunopharma Announces the Acceptance of Three..
29/02/202406:07EDGAR2Form 8-K - Current report
29/02/202406:05GLOBELyell Immunopharma Reports Business Highlights and Financial..
27/02/202406:05GLOBELyell Immunopharma Announces Participation in March Investor..
14/02/202410:24EDGAR2Form 4 - Statement of changes in beneficial ownership of..
14/02/202410:22EDGAR2Form 4 - Statement of changes in beneficial ownership of..
14/02/202410:19EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04/01/202406:05GLOBELyell Immunopharma to Participate in 42nd Annual J.P. Morgan..
21/11/202310:55EDGAR2Form 4 - Statement of changes in beneficial ownership of..
21/11/202310:54EDGAR2Form 4 - Statement of changes in beneficial ownership of..
21/11/202310:52EDGAR2Form 4 - Statement of changes in beneficial ownership of..
21/11/202306:26EDGAR2Form 8-K - Current report
10/11/202306:05GLOBELyell Immunopharma Receives FDA Orphan Drug Designation for..
08/11/202306:14EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
08/11/202306:08EDGAR2Form 8-K - Current report
08/11/202306:05GLOBELyell Immunopharma Reports Business Highlights and Financial..
31/10/202322:00GLOBELyell Immunopharma Presentations at SITC Highlight New..
27/09/202322:00GLOBELyell Immunopharma Announces the Acceptance of Six Abstracts..
11/09/202322:16EDGAR2Form 8-K - Current report
11/09/202321:00PRNUSCellares and Lyell to Evaluate Automated Manufacturing of..
01/09/202305:05GLOBELyell Immunopharma to Participate in Upcoming Investor..
09/08/202305:21EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
09/08/202305:10EDGAR2Form 8-K - Current report
09/08/202305:05GLOBELyell Immunopharma Reports Business Highlights and Financial..
06/07/202305:05GLOBELyell Immunopharma Appoints Matthew Lang as Chief Business..
08/06/202305:05GLOBELyell Immunopharma to Participate in the Goldman Sachs..

최근 히스토리

Delayed Upgrade Clock